1. Home
  2. BRSP vs ABCL Comparison

BRSP vs ABCL Comparison

Compare BRSP & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRSP
  • ABCL
  • Stock Information
  • Founded
  • BRSP 2017
  • ABCL 2012
  • Country
  • BRSP United States
  • ABCL Canada
  • Employees
  • BRSP N/A
  • ABCL N/A
  • Industry
  • BRSP Real Estate Investment Trusts
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRSP Real Estate
  • ABCL Health Care
  • Exchange
  • BRSP Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • BRSP 789.8M
  • ABCL 818.2M
  • IPO Year
  • BRSP 2018
  • ABCL 2020
  • Fundamental
  • Price
  • BRSP $6.05
  • ABCL $3.03
  • Analyst Decision
  • BRSP Hold
  • ABCL Buy
  • Analyst Count
  • BRSP 5
  • ABCL 3
  • Target Price
  • BRSP $7.06
  • ABCL $8.00
  • AVG Volume (30 Days)
  • BRSP 924.6K
  • ABCL 3.9M
  • Earning Date
  • BRSP 02-18-2025
  • ABCL 02-27-2025
  • Dividend Yield
  • BRSP 10.58%
  • ABCL N/A
  • EPS Growth
  • BRSP N/A
  • ABCL N/A
  • EPS
  • BRSP N/A
  • ABCL N/A
  • Revenue
  • BRSP $358,805,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • BRSP N/A
  • ABCL N/A
  • Revenue Next Year
  • BRSP N/A
  • ABCL $37.26
  • P/E Ratio
  • BRSP N/A
  • ABCL N/A
  • Revenue Growth
  • BRSP N/A
  • ABCL N/A
  • 52 Week Low
  • BRSP $5.07
  • ABCL $2.34
  • 52 Week High
  • BRSP $7.04
  • ABCL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • BRSP 62.91
  • ABCL 45.64
  • Support Level
  • BRSP $5.56
  • ABCL $2.88
  • Resistance Level
  • BRSP $6.13
  • ABCL $3.60
  • Average True Range (ATR)
  • BRSP 0.17
  • ABCL 0.20
  • MACD
  • BRSP 0.05
  • ABCL -0.01
  • Stochastic Oscillator
  • BRSP 86.00
  • ABCL 20.83

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: